{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:09:20Z","timestamp":1784023760997,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"DOI":"10.1007\/s11427-025-3309-7","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:09:49Z","timestamp":1784016589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plant-derived CTLA-4-targeting miR152 via lipid nanoparticles potentiates doxorubicin efficacy in breast cancer immunochemotherapy"],"prefix":"10.1007","author":[{"given":"Hanyi","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"3309_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L.R., El Sahly, H.M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S.A., Rouphael, N., Creech, C.B., et al. (2021). Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384, 403\u2013416.","journal-title":"N Engl J Med"},{"key":"3309_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.12688\/f1000research.18888.1","volume":"8","author":"ART Bergin","year":"2019","unstructured":"Bergin, A.R.T., and Loi, S. (2019). Triple-negative breast cancer: recent treatment advances. F1000Res 8, 1342.","journal-title":"F1000Res"},{"key":"3309_CR3","first-page":"S514","volume":"32","author":"S Bhalla","year":"2017","unstructured":"Bhalla, S., and Hauck, K. (2017). Hypophysitis and adrenal insufficiency secondary to ipilimumab and nivolumab: a nearly life threatening side effect of novel immunotherapy agents. J Gen Intern Med 32, S514\u2013S514.","journal-title":"J Gen Intern Med"},{"key":"3309_CR4","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.bpj.2021.03.012","volume":"120","author":"ML Brader","year":"2021","unstructured":"Brader, M.L., Williams, S.J., Banks, J.M., Hui, W.H., Zhou, Z.H., and Jin, L. (2021). Encapsulation state of messenger RNA inside lipid nanoparticles. Biophys J 120, 2766\u20132770.","journal-title":"Biophys J"},{"key":"3309_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., and Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74, 229\u2013263.","journal-title":"CA Cancer J Clin"},{"key":"3309_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/vaccines9010065","volume":"9","author":"MD Buschmann","year":"2021","unstructured":"Buschmann, M.D., Carrasco, M.J., Alishetty, S., Paige, M., Alameh, M.G., and Weissman, D. (2021). Nanomaterial delivery systems for mRNA vaccines. Vaccines 9, 65.","journal-title":"Vaccines"},{"key":"3309_CR7","doi-asserted-by":"publisher","first-page":"e2304249","DOI":"10.1002\/adhm.202304249","volume":"13","author":"C Cao","year":"2024","unstructured":"Cao, C., Lu, Y., Pan, X., Lin, Y., Fan, S., Niu, J., Lin, S., Tan, H., Wang, Y., Cui, S., et al. (2024). Time and space dual-blockade strategy for highly invasive nature of triple-negative breast cancer in enhanced sonodynamic therapy based on Fe-MOF nanoplatforms. Adv Healthc Mater 13, e2304249.","journal-title":"Adv Healthc Mater"},{"key":"3309_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41422-020-0389-3","volume":"31","author":"Q Chen","year":"2021","unstructured":"Chen, Q., Zhang, F., Dong, L., Wu, H., Xu, J., Li, H., Wang, J., Zhou, Z., Liu, C., Wang, Y., et al. (2021). SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs. Cell Res 31, 247\u2013258.","journal-title":"Cell Res"},{"key":"3309_CR9","doi-asserted-by":"publisher","first-page":"2303370","DOI":"10.1002\/adma.202303370","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng, M.H.Y., Leung, J., Zhang, Y., Strong, C., Basha, G., Momeni, A., Chen, Y., Jan, E., Abdolahzadeh, A., Wang, X., et al. (2023). Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv Mater 35, 2303370.","journal-title":"Adv Mater"},{"key":"3309_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/cr.2016.13","volume":"26","author":"AR Chin","year":"2016","unstructured":"Chin, A.R., Fong, M.Y., Somlo, G., Wu, J., Swiderski, P., Wu, X., and Wang, S.E. (2016). Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res 26, 217\u2013228.","journal-title":"Cell Res"},{"key":"3309_CR11","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1158\/1538-7445.AM2023-5113","volume":"83","author":"BG Cuiffo","year":"2023","unstructured":"Cuiffo, B.G., Boone, A., Yan, D., Maxwell, M., Rivest, B., Cardia, J., and Fricker, S.P. (2023). Abstract 5113: INTASYL self-delivering RNAi therapeutic dual targeting PD-1 and CTLA-4 provides synergistic antitumor efficacy in the treatment of murine colon cancer in vivo. Cancer Res 83, 5113.","journal-title":"Cancer Res"},{"key":"3309_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/CMR.0000000000000165","volume":"25","author":"KM De Felice","year":"2015","unstructured":"De Felice, K.M., Gupta, A., Rakshit, S., Khanna, S., Kottschade, L.A., Finnes, H.D., Papadakis, K.A., Loftus, E.V., Raffals, L.E., and Markovic, S.N. (2015). Ipilimumab-induced colitis in patients with metastatic melanoma. Melanoma Res 25, 321\u2013327.","journal-title":"Melanoma Res"},{"key":"3309_CR13","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1158\/1538-7445.AM2023-5949","volume":"83","author":"W Du","year":"2023","unstructured":"Du, W., Johnston, A., Nair, P., Zhu, J., Win, K.S., Zhou, B., Phillip, J., Wu, P.H., and Wirtz, D. (2023). Abstract 5949: modulate TAM infiltration at cancer-immune interface by targeting at monocyte migration. Cancer Res 83, 5949.","journal-title":"Cancer Res"},{"key":"3309_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fonc.2015.00044","volume":"5","author":"J Dudas","year":"2015","unstructured":"Dudas, J. (2015). Supportive and rejective functions of tumor stroma on tumor cell growth, survival, and invasivity: the cancer evolution. Front Oncol 5, 44.","journal-title":"Front Oncol"},{"key":"3309_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/micmic\/ozad044","volume":"29","author":"YHA Elewa","year":"2023","unstructured":"Elewa, Y.H.A., Abd Elwakil, M.M., Harashima, H., Mohamed, S.K.A., and Zahran, M. H. (2023). Microenvironmental changes in mediastinal fat-associated lymphoid clusters and lungs in early and late stages of metastatic lung cancer induction. Microsc Microanal 29, 1228\u20131243.","journal-title":"Microsc Microanal"},{"key":"3309_CR16","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1586\/era.12.147","volume":"12","author":"LA Emens","year":"2012","unstructured":"Emens, L.A. (2012). Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade. Expert Rev Anticancer Ther 12, 1597\u20131611.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3309_CR17","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/gb-2003-5-1-r1","volume":"5","author":"AJ Enright","year":"2003","unstructured":"Enright, A.J., John, B., Gaul, U., Tuschl, T., Sander, C., and Marks, D.S. (2003). MicroRNA targets in Drosophila. Genome Biol 5, R1.","journal-title":"Genome Biol"},{"key":"3309_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","volume":"172","author":"MJ Ernsting","year":"2013","unstructured":"Ernsting, M.J., Murakami, M., Roy, A., and Li, S.D. (2013). Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release 172, 782\u2013794.","journal-title":"J Control Release"},{"key":"3309_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nsmb.2296","volume":"19","author":"MR Fabian","year":"2012","unstructured":"Fabian, M.R., and Sonenberg, N. (2012). The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 19, 586\u2013593.","journal-title":"Nat Struct Mol Biol"},{"key":"3309_CR20","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood, B., Najafi, M., and Mortezaee, K. (2019). CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol 234, 8509\u20138521.","journal-title":"J Cell Physiol"},{"key":"3309_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.09.047","volume":"551","author":"H Farzaneh","year":"2018","unstructured":"Farzaneh, H., Ebrahimi Nik, M., Mashreghi, M., Saberi, Z., Jaafari, M.R., and Teymouri, M. (2018). A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy. Int J Pharm 551, 300\u2013308.","journal-title":"Int J Pharm"},{"key":"3309_CR22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1261\/rna.28106","volume":"12","author":"Y Fedorov","year":"2006","unstructured":"Fedorov, Y., Anderson, E.M., Birmingham, A., Reynolds, A., Karpilow, J., Robinson, K., Leake, D., Marshall, W.S., and Khvorova, A. (2006). Off-target effects by siRNA can induce toxic phenotype. RNA 12, 1188\u20131196.","journal-title":"RNA"},{"key":"3309_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood.V128.22.344.344","volume":"128","author":"G Garcia-Manero","year":"2016","unstructured":"Garcia-Manero, G., Daver, N.G., Montalban-Bravo, G., Jabbour, E.J., DiNardo, C.D., Kornblau, S.M., Bose, P., Alvarado, Y., Ohanian, M., Borthakur, G., et al. (2016). A phase II study evaluating the combination of nivolumab (Nivo) or ipilimumab (Ipi) with azacitidine in Pts with previously treated or untreated myelodysplastic syndromes (MDS). Blood 128, 344.","journal-title":"Blood"},{"key":"3309_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10555-010-9249-9","volume":"29","author":"DS Guttery","year":"2010","unstructured":"Guttery, D.S., Shaw, J.A., Lloyd, K., Pringle, J.H., and Walker, R.A. (2010). Expression of tenascin-C and its isoforms in the breast. Cancer Metastasis Rev 29, 595\u2013606.","journal-title":"Cancer Metastasis Rev"},{"key":"3309_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris, J.M., and Chess, R.B. (2003). Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2, 214\u2013221.","journal-title":"Nat Rev Drug Discov"},{"key":"3309_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","volume":"335","author":"KJ Hassett","year":"2021","unstructured":"Hassett, K.J., Higgins, J., Woods, A., Levy, B., Xia, Y., Hsiao, C.J., Acosta, E., Almarsson, \u00d6., Moore, M.J., and Brito, L.A. (2021). Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J Control Release 335, 237\u2013246.","journal-title":"J Control Release"},{"key":"3309_CR27","doi-asserted-by":"publisher","first-page":"S374","DOI":"10.14309\/00000434-201310001-01271","volume":"108","author":"A Hinds","year":"2013","unstructured":"Hinds, A., Ahmad, D., Muenster, J., Berg, Z., Lopez, K., Holly, J.S., Matteson, M., and Bechtold, M. (2013). Ipilimumab-induced colitis: a rare but serious side effect. Am J Gastroenterol 108, S374\u2013S375.","journal-title":"Am J Gastroenterol"},{"key":"3309_CR28","first-page":"798","volume":"63","author":"AA Howeedy","year":"1990","unstructured":"Howeedy, A.A., Virtanen, I., Laitinen, L., Gould, N.S., Koukoulis, G.K., and Gould, V.E. (1990). Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 63, 798\u2013806.","journal-title":"Lab Invest"},{"key":"3309_CR29","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1016\/j.transproceed.2016.07.019","volume":"48","author":"A Jose","year":"2016","unstructured":"Jose, A., Yiannoullou, P., Bhutani, S., Denley, H., Morton, M., Picton, M., Summers, A., van Dellen, D., and Augustine, T. (2016). Renal allograft failure after ipilimumab therapy for metastatic melanoma: a case report and review of the literature. Transplant Proc 48, 3137\u20133141.","journal-title":"Transplant Proc"},{"key":"3309_CR30","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/cells12151999","volume":"12","author":"A Kadriya","year":"2023","unstructured":"Kadriya, A., and Falah, M. (2023). Nanoscale phytosomes as an emerging modality for cancer therapy. Cells 12, 1999.","journal-title":"Cells"},{"key":"3309_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5152\/tjg.2022.21895","volume":"34","author":"M Kantarc\u0131o\u011flu","year":"2023","unstructured":"Kantarc\u0131o\u011flu, M., Y\u0131ld\u0131r\u0131m, G., Akp\u0131nar Oktar, P., Yanbakan, S., \u00d6zer, Z.B., Yurtsever Sar\u0131ca, D., Ta\u015fdelen, S., Bayrak, E., Ak\u0131n Bal\u0131, D.F., \u00d6zt\u00fcrk, S., et al. (2023). Coffee-derived exosome-like nanoparticles: are they the secret heroes? Turkish J Gastroenterol 34, 161\u2013169.","journal-title":"Turkish J Gastroenterol"},{"key":"3309_CR32","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ng2135","volume":"39","author":"M Kertesz","year":"2007","unstructured":"Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., and Segal, E. (2007). The role of site accessibility in microRNA target recognition. Nat Genet 39, 1278\u20131284.","journal-title":"Nat Genet"},{"key":"3309_CR33","doi-asserted-by":"publisher","first-page":"e000493","DOI":"10.1136\/jitc-2019-000493","volume":"8","author":"KM Knudson","year":"2020","unstructured":"Knudson, K.M., Hicks, K.C., Ozawa, Y., Schlom, J., and Gameiro, S.R. (2020). Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1\/IL-15 superagonist. J Immunother Cancer 8, e000493.","journal-title":"J Immunother Cancer"},{"key":"3309_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7150\/ijbs.65258","volume":"18","author":"CY Kong","year":"2022","unstructured":"Kong, C.Y., Guo, Z., Song, P., Zhang, X., Yuan, Y.P., Teng, T., Yan, L., and Tang, Q.Z. (2022). Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death. Int J Biol Sci 18, 760\u2013770.","journal-title":"Int J Biol Sci"},{"key":"3309_CR35","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kr\u00fcger","year":"2006","unstructured":"Kr\u00fcger, J., and Rehmsmeier, M. (2006). RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34, W451\u2013W454..","journal-title":"Nucleic Acids Res"},{"key":"3309_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/nat.2018.0721","volume":"28","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni, J.A., Cullis, P.R., and van der Meel, R. (2018). Lipid nanoparticles enabling gene therapies: from concepts to clinical utility. Nucleic Acid Ther 28, 146\u2013157.","journal-title":"Nucleic Acid Ther"},{"key":"3309_CR37","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3390\/cancers13122978","volume":"13","author":"CJ Li","year":"2021","unstructured":"Li, C.J., Tzeng, Y.D.T., Chiu, Y.H., Lin, H.Y., Hou, M.F., and Chu, P.Y. (2021). Pathogenesis and potential therapeutic targets for triple-negative breast cancer. Cancers 13, 2978.","journal-title":"Cancers"},{"key":"3309_CR38","doi-asserted-by":"publisher","first-page":"23TR01","DOI":"10.1088\/1361-6560\/acfade","volume":"68","author":"J Li","year":"2023","unstructured":"Li, J., Sheng, D., Chen, J., You, C., Liu, S., Xu, H., and Chang, C. (2023). Artificial intelligence in breast imaging: potentials and challenges. Phys Med Biol 68, 23TR01.","journal-title":"Phys Med Biol"},{"key":"3309_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11427-018-9508-0","volume":"62","author":"X Li","year":"2019","unstructured":"Li, X., Liang, Z., Du, J., Wang, Z., Mei, S., Li, Z., Zhao, Y., Zhao, D., Ma, Y., Ye, J., et al. (2019). Herbal decoctosome is a novel form of medicine. Sci China Life Sci 62, 333\u2013348.","journal-title":"Sci China Life Sci"},{"key":"3309_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12986-018-0305-8","volume":"15","author":"Z Li","year":"2018","unstructured":"Li, Z., Xu, R., and Li, N. (2018). MicroRNAs from plants to animals, do they define a new messenger for communication? Nutr Metab (Lond) 15, 68.","journal-title":"Nutr Metab (Lond)"},{"key":"3309_CR41","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41467-020-17395-y","volume":"11","author":"ZL Li","year":"2020","unstructured":"Li, Z.L., Zhang, H.L., Huang, Y., Huang, J.H., Sun, P., Zhou, N.N., Chen, Y.H., Mai, J., Wang, Y., Yu, Y., et al. (2020). Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun 11, 3806.","journal-title":"Nat Commun"},{"key":"3309_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin, Y., Xu, J., and Lan, H. (2019). Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol 12, 76.","journal-title":"J Hematol Oncol"},{"key":"3309_CR43","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3390\/diagnostics13162701","volume":"13","author":"J Link","year":"2023","unstructured":"Link, J., Thon, C., Petkevicius, V., Steponaitiene, R., Malfertheiner, P., Kupcinskas, J., and Link, A. (2023). The translational impact of plant-derived xeno-miRNA miR-168 in gastrointestinal cancers and preneoplastic conditions. Diagnostics 13, 2701.","journal-title":"Diagnostics"},{"key":"3309_CR44","doi-asserted-by":"publisher","first-page":"108627","DOI":"10.1016\/j.jnutbio.2021.108627","volume":"92","author":"J Liu","year":"2021","unstructured":"Liu, J., Wang, F., Song, H., Weng, Z., Bao, Y., Fang, Y., Tang, X., and Shen, X. (2021). Soybean-derived gma-miR159a alleviates colon tumorigenesis by suppressing TCF7\/MYC in mice. J Nutr Biochem 92, 108627.","journal-title":"J Nutr Biochem"},{"key":"3309_CR45","doi-asserted-by":"publisher","first-page":"110951","DOI":"10.1016\/j.intimp.2023.110951","volume":"124","author":"J Liu","year":"2023","unstructured":"Liu, J., Xu, T., Pan, D., Fan, J., Fu, Y., Huang, X., Zhao, W., Dong, X., Zhang, S., Kuerban, K., et al. (2023). A collagen-binding SIRP\u03b1Fc fusion protein for targeted cancer immunotherapy. Int Immunopharmacol 124, 110951.","journal-title":"Int Immunopharmacol"},{"key":"3309_CR46","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1007\/s11427-024-2657-y","volume":"67","author":"Y Liu","year":"2024","unstructured":"Liu, Y., and Zheng, Z. (2024). Understanding the global cancer statistics 2022: growing cancer burden. Sci China Life Sci 67, 2274\u20132276.","journal-title":"Sci China Life Sci"},{"key":"3309_CR47","doi-asserted-by":"publisher","first-page":"102325","DOI":"10.1016\/j.nantod.2024.102325","volume":"57","author":"R Ma","year":"2024","unstructured":"Ma, R., Li, Y., Wei, Y., Zhou, J., Ma, J., Zhang, M., Tu, J., Jiang, J., Xie, S., Tan, W., et al. (2024). The dynamic process of mRNA delivery by lipid nanoparticles in vivo. Nano Today 57, 102325.","journal-title":"Nano Today"},{"key":"3309_CR48","doi-asserted-by":"publisher","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary, S.E., Lin, K.S., Shi, C.Y., Pham, T.M., Bisaria, N., Kelley, G.M., and Bartel, D. P. (2019). The biochemical basis of microRNA targeting efficacy. Science 366, eaav1741.","journal-title":"Science"},{"key":"3309_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbcan.2013.05.003","volume":"1836","author":"S Mocellin","year":"2013","unstructured":"Mocellin, S., and Nitti, D. (2013). CTLA-4 blockade and the renaissance of cancer immunotherapy. Biochim Biophys Acta Rev Cancer 1836, 187\u2013196.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3309_CR50","doi-asserted-by":"publisher","first-page":"608024","DOI":"10.3389\/fimmu.2020.608024","volume":"11","author":"D Oyewole-Said","year":"2020","unstructured":"Oyewole-Said, D., Konduri, V., Vazquez-Perez, J., Weldon, S.A., Levitt, J.M., and Decker, W.K. (2020). Beyond T-cells: functional characterization of CTLA-4 expression in immune and non-immune cell types. Front Immunol 11, 608024.","journal-title":"Front Immunol"},{"key":"3309_CR51","doi-asserted-by":"publisher","first-page":"113945","DOI":"10.1016\/j.jconrel.2025.113945","volume":"384","author":"Y Ren","year":"2025","unstructured":"Ren, Y., Lin, L., Abdallah, M., Zhu, X., Liu, H., Fabb, S.A., Payne, T.J., Pouton, C.W., Johnston, A.P.R., and Trevaskis, N.L. (2025). Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection. J Control Release 384, 113945.","journal-title":"J Control Release"},{"key":"3309_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","volume":"818","author":"K Renu","year":"2018","unstructured":"Renu, K., V.G., A., P.B., T.P., and Arunachalam, S. (2018). Molecular mechanism of doxorubicin-induced cardiomyopathy\u2014an update. Eur J Pharmacol 818, 241\u2013253.","journal-title":"Eur J Pharmacol"},{"key":"3309_CR53","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1080\/15476286.2018.1551693","volume":"15","author":"Sanchita","year":"2018","unstructured":"Sanchita, Trivedi, R., Asif, M.H., and Trivedi, P.K. (2018). Dietary plant miRNAs as an augmented therapy: cross-kingdom gene regulation. RNA Biol 15, 1433\u20131439.","journal-title":"RNA Biol"},{"key":"3309_CR54","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3390\/cells14231905","volume":"14","author":"A Sarkar","year":"2025","unstructured":"Sarkar, A., Sarkar, S., Anwar, A., Kim, J.W., Shim, J.H., and John, A.A. (2025). The growing significance of microRNAs in osteoporosis. Cells 14, 1905.","journal-title":"Cells"},{"key":"3309_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1369\/0022155411410885","volume":"59","author":"B Shi","year":"2011","unstructured":"Shi, B., Keough, E., Matter, A., Leander, K., Young, S., Carlini, E., Sachs, A.B., Tao, W., Abrams, M., Howell, B., et al. (2011). Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery. J Histochem Cytochem 59, 727\u2013740.","journal-title":"J Histochem Cytochem"},{"key":"3309_CR56","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1006\/mthe.2002.0602","volume":"5","author":"HY Shi","year":"2002","unstructured":"Shi, H.Y., Liang, R., Templeton, N.S., and Zhang, M. (2002). Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model. Mol Ther 5, 755\u2013761.","journal-title":"Mol Ther"},{"key":"3309_CR57","doi-asserted-by":"publisher","first-page":"1512047","DOI":"10.3389\/fpls.2024.1512047","volume":"15","author":"L Shi","year":"2024","unstructured":"Shi, L., Guo, C., Fang, M., Yang, Y., Yin, F., and Shen, Y. (2024a). Cross-kingdom regulation of plant microRNAs: potential application in crop improvement and human disease therapeutics. Front Plant Sci 15, 1512047.","journal-title":"Front Plant Sci"},{"key":"3309_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3892\/ol.2024.14306","volume":"27","author":"S Shi","year":"2024","unstructured":"Shi, S., Zhang, Z.G., Sang, Y.Z., Sun, J., and Ma, H.Y. (2024b). A meta- and bioinformatics analysis of maspin expression levels influencing the prognosis of patients with breast cancer. Oncol Lett 27, 173.","journal-title":"Oncol Lett"},{"key":"3309_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jconrel.2018.10.034","volume":"292","author":"Y Shi","year":"2018","unstructured":"Shi, Y., Jiang, Y., Cao, J., Yang, W., Zhang, J., Meng, F., and Zhong, Z. (2018). Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes. J Control Release 292, 163\u2013171.","journal-title":"J Control Release"},{"key":"3309_CR60","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.3390\/pharmaceutics14122677","volume":"14","author":"L Sun","year":"2022","unstructured":"Sun, L., Zuo, C., Liu, X., Guo, Y., Wang, X., Dong, Z., and Han, M. (2022). Combined photothermal therapy and Lycium barbarum polysaccharide for topical administration to improve the efficacy of doxorubicin in the treatment of breast cancer. Pharmaceutics 14, 2677.","journal-title":"Pharmaceutics"},{"key":"3309_CR61","first-page":"1","volume-title":"Proceedings of 2019 IEEE 6th Portuguese Meeting on Bioengineering. (Lisbon, Portugal)","author":"C Ulpiano","year":"2019","unstructured":"Ulpiano, C., Alves, C.A.P., Silva-Santos, A.R., Serra, J., da Silva, C.L., and Monteiro, G. A. (2019). RNAi as a tool to inhibit the angiogenic potential of human mesenchymal stem\/stromal cells in malignancy. In Proceedings of 2019 IEEE 6th Portuguese Meeting on Bioengineering. (Lisbon, Portugal), pp. 1\u20134."},{"key":"3309_CR62","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrc3237","volume":"12","author":"M Vanneman","year":"2012","unstructured":"Vanneman, M., and Dranoff, G. (2012). Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 12, 237\u2013251.","journal-title":"Nat Rev Cancer"},{"key":"3309_CR63","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1021\/acs.nanolett.9b02127","volume":"19","author":"S Wang","year":"2019","unstructured":"Wang, S., Shao, J., Li, Z., Ren, Q., Yu, X.F., and Liu, S. (2019). Black phosphorus-based multimodal nanoagent: showing targeted combinatory therapeutics against cancer metastasis. Nano Lett 19, 5587\u20135594.","journal-title":"Nano Lett"},{"key":"3309_CR64","doi-asserted-by":"publisher","first-page":"102943","DOI":"10.1016\/j.ctrv.2025.102943","volume":"137","author":"N Wu","year":"2025","unstructured":"Wu, N., Yang, N., Zhang, S., Wu, H., Fang, X., Lin, W., Zhang, Y., Qi, X., and Gong, Y. (2025). Chimeric antigen receptor NK cells for breast cancer immunotherapy. Cancer Treat Rev 137, 102943.","journal-title":"Cancer Treat Rev"},{"key":"3309_CR65","doi-asserted-by":"publisher","first-page":"124110","DOI":"10.1016\/j.ijbiomac.2023.124110","volume":"239","author":"Y Xiong","year":"2023","unstructured":"Xiong, Y., Li, N., Han, M., Ye, F., Liu, T., Ye, H., Zheng, T., Wu, J., Li, Y., Lv, S., et al. (2023). Rhodiola rosea polysaccharides-based nanoparticles loaded with DOX boosts chemo-immunotherapy for triple-negative breast cancer by re-educating tumor-associated macrophages. Int J Biol Macromol 239, 124110.","journal-title":"Int J Biol Macromol"},{"key":"3309_CR66","first-page":"483","volume":"28","author":"H Ye","year":"2024","unstructured":"Ye, H., L\u00fc, S., Li, Y., and Dong, Z. (2024). Plant-derived miR261, miR354 and miR194 regulate the proliferation of multiple tumor cells and target HDAC-2 or CTLA-4. Life Sci Res 28, 483\u2013492.","journal-title":"Life Sci Res"},{"key":"3309_CR67","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1158\/1538-7445.AM2023-5069","volume":"83","author":"B Yoo","year":"2023","unstructured":"Yoo, B., Sojoodi, M., Jordan, V.C., Pantazopoulos, P., Ghosh, S., Caravan, P., and Medarova, Z. (2023). Abstract 5069: cancer immunotherapy based on the RNAi-based PD-L1 inhibitor, MN-siPDL1, demonstrates efficacy in preclinical pancreatic adenocarcinoma. Cancer Res 83, 5069.","journal-title":"Cancer Res"},{"key":"3309_CR68","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1158\/1538-7445.AM2022-1495","volume":"82","author":"AM Yu","year":"2022","unstructured":"Yu, A.M. (2022). Abstract 1495: bioengineered RNAi molecules for cancer research and experimental therapy. Cancer Res 82, 1495.","journal-title":"Cancer Res"},{"key":"3309_CR69","doi-asserted-by":"publisher","first-page":"baz070","DOI":"10.1093\/database\/baz070","volume":"2019","author":"D Yu","year":"2019","unstructured":"Yu, D., Lu, J., Shao, W., Ma, X., Xie, T., Ito, H., Wang, T., Xu, M., Wang, H., and Meng, Y. (2019). MepmiRDB: a medicinal plant microRNA database. Database 2019, baz070.","journal-title":"Database"},{"key":"3309_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cr.2011.158","volume":"22","author":"L Zhang","year":"2012","unstructured":"Zhang, L., Hou, D., Chen, X., Li, D., Zhu, L., Zhang, Y., Li, J., Bian, Z., Liang, X., Cai, X., et al. (2012). Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 22, 107\u2013126.","journal-title":"Cell Res"},{"key":"3309_CR71","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/D0BM01609H","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang, R., El-Mayta, R., Murdoch, T.J., Warzecha, C.C., Billingsley, M.M., Shepherd, S. J., Gong, N., Wang, L., Wilson, J.M., Lee, D., et al. (2021). Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomater Sci 9, 1449\u20131463.","journal-title":"Biomater Sci"},{"key":"3309_CR72","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1039\/D2FO03477H","volume":"14","author":"WJ Zhang","year":"2023","unstructured":"Zhang, W.J., Li, Y.Y., Xiang, Z.H., Deng, J., Li, W., Lin, Q.L., Fang, Y., Liu, F., Bai, J., Zhang, L., et al. (2023). Emerging evidence on the effects of plant-derived microRNAs in colorectal cancer: a review. Food Funct 14, 691\u2013702.","journal-title":"Food Funct"},{"key":"3309_CR73","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s11427-022-2219-0","volume":"66","author":"D Zhao","year":"2023","unstructured":"Zhao, D., Qin, Y., Liu, J., Tang, K., Lu, S., Liu, Z., Lin, Y., Zhang, C., Huang, F., Chang, J., et al. (2023). Orally administered BZL-sRNA-20 oligonucleotide targeting TLR4 effectively ameliorates acute lung injury in mice. Sci China Life Sci 66, 1589\u20131599.","journal-title":"Sci China Life Sci"},{"key":"3309_CR74","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s11427-024-2810-y","volume":"68","author":"Q Zhu","year":"2025","unstructured":"Zhu, Q., Yao, Y., Chen, R., Han, B., Wang, S., Li, L., Sun, K., Zheng, R., and Wei, W. (2025). Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022. Sci China Life Sci 68, 1478\u20131486.","journal-title":"Sci China Life Sci"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-025-3309-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:02:13Z","timestamp":1784023333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-025-3309-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":74,"alternative-id":["3309"],"URL":"https:\/\/doi.org\/10.1007\/s11427-025-3309-7","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The animal experiments were conducted in accordance with the National Regulations for the Care and Use of Laboratory Animals in China and the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals. It was approved by the Professional Committee of Animal Experimentation of Peking Union Medical College (Approval No. SLXD-20230425013).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}